The authors suggested that targeting lysophosphatidic acid (LPA) signaling in chronic inflammatory conditions may have rescued T cell function and promoted antiviral and antitumor immunity.
[Proceedings of the National Academy of Sciences of the United States of America]
Sorry, but the selected Zotpress account can't be found.
